Article (Scientific journals)
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
Vernimmen, D.; Guéders, Maud; Pisvin, Sonia et al.
2003In British Journal of Cancer, 89 (5), p. 899-906
Peer Reviewed verified by ORBi
 

Files


Full Text
89-6601200a.pdf
Publisher postprint (222.19 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
immunocytochemistry; ERBB2 promoter; AP-2 transcription factor; human
Abstract :
[en] The ERBB2 gene is overexpressed in 30% of breast cancers and this has been correlated with poor prognosis. ERBB2 is upregulated in other cancers such as prostate, pancreas, colon and ovary. In breast cancer cells, the mechanisms leading to ERBB2 gene overexpression are increased transcription and gene amplification. In these cancers, AP-2 transcription factors are involved in ERBB2 overexpression, and AP-2 levels are correlated with p185(c-erbB-2) levels. In this work, we wanted to know if the same molecular mechanisms are responsible for the ERBB2 upregulation in non-breast cancers. We compared ERBB2 gene copy number, p185(c-erbB-2) and mRNA levels with AP-2 levels in several ovary, prostate, colon and pancreas cancer cells. A moderate expression of erbB-2 mRNA and protein were observed in some cells without gene amplification. In contrast to breast cancer cells, AP-2 factors were absent or low in some non-breast cells which did express ERBB2. It is thus likely that AP-2 is not a major player in the increased levels of erbB-2 transcripts in non-breast cancer cells. The transcriptional activity of the ERBB2 promoter in colon and ovary cancer cells was estimated using reporter vectors. The results showed that the promoter regions involved in ERBB2 gene overexpression in breast cancer cells are different from those that lead to the gene upregulation in colon and ovary cancers. In conclusion, our results indicate that different transcriptional and post-transcriptional mechanisms are responsible for the increased levels of erbB-2 transcript and protein in breast and non-breast cancer cells.
Disciplines :
Oncology
Author, co-author :
Vernimmen, D.
Guéders, Maud ;  Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Pisvin, Sonia ;  Centre Hospitalier Universitaire de Liège - CHU > Centre de diagnostic moleculaire
Delvenne, Philippe ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Winkler, Rose ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Language :
English
Title :
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
Publication date :
01 September 2003
Journal title :
British Journal of Cancer
ISSN :
0007-0920
eISSN :
1532-1827
Publisher :
Nature Publishing Group, London, United Kingdom
Volume :
89
Issue :
5
Pages :
899-906
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 06 September 2010

Statistics


Number of views
113 (3 by ULiège)
Number of downloads
172 (0 by ULiège)

Scopus citations®
 
75
Scopus citations®
without self-citations
73
OpenCitations
 
66

Bibliography


Similar publications



Contact ORBi